Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023
- Written by PR Newswire
SAN FRANCISCO and SEONGNAM, South Korea, Jan. 3, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis and inflammation, announced that the company is presenting at Biotech Showcase™ 2023.
Pavel Printsev, Director of Business Development of Bridge...
Read more: Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023














